SNPX: Synaptogenix Company Aggregate Debts

This daily price chart illustrates the price action of Synaptogenix, Inc. (SNPX), where the individual debt level stands at 0.00. Synaptogenix, Inc. (SNPX) is recruiting leading neurobiologists to combat dementia, establishing an academic environment supported by an option-based incentive system. The business relies on patents designed to capture the global market through low-cost mass production of pharmaceuticals, while research centers upgrade their equipment to expand synthesis volumes.

This metric aggregates the total volume of borrowed capital, determining the level of financial stability and the degree of the business's dependence on external creditors. Analyzing the change in liabilities allows for an assessment of the default risk for Synaptogenix, Inc. (SNPX), a pre-revenue neurobiology micro-cap whose viability depends not on profit, but on the ability to raise funds to sustain patent research amidst fierce competition.